0001415889-24-001775.txt : 20240124
0001415889-24-001775.hdr.sgml : 20240124
20240124180027
ACCESSION NUMBER: 0001415889-24-001775
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240122
FILED AS OF DATE: 20240124
DATE AS OF CHANGE: 20240124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NIVEN RALPH
CENTRAL INDEX KEY: 0001168060
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40544
FILM NUMBER: 24558061
MAIL ADDRESS:
STREET 1: C/O AEROVATE THERAPEUTICS, INC.
STREET 2: 200 BERKELEY STREET, FLOOR 18
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc.
CENTRAL INDEX KEY: 0001798749
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 831377888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 930 WINTER STREET
STREET 2: SUITE M-500
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-443-2400
MAIL ADDRESS:
STREET 1: 930 WINTER STREET
STREET 2: SUITE M-500
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4-01242024_060107.xml
X0508
4
2024-01-22
0001798749
Aerovate Therapeutics, Inc.
AVTE
0001168060
NIVEN RALPH
C/O AEROVATE THERAPEUTICS, INC.
930 WINTER STREET, SUITE M-500
WALTHAM
MA
02451
false
true
false
false
CHIEF SCIENTIFIC OFFICER
0
Stock Option (Right to Buy)
20
2024-01-22
4
A
0
66586
0
A
2034-01-21
Common Stock
66586
66586
D
This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on February 22, 2024.
/s/ George A. Eldridge, Attorney-in-Fact
2024-01-24